Can coenzyme Q10 supplementation effectively reduce human tumour necrosis factor-α and interleukin-6 levels in chronic diseases? Protocol for a systematic review and meta-analysis of randomised controlled trials

INTRODUCTION: Inflammation, as a critical factor, can cause numerous chronic diseases by creating various proinflammatory cytokines. Coenzyme Q10 (CoQ10) can potentially exert an anti-inflammatory agent; in turn, this agent can reduce the systemic inflammatory response. The aims of this study are to...

Descripción completa

Detalles Bibliográficos
Autores principales: Farsi, Farnaz, Heshmati, Javad, Janani, Leila, Irandoost, Pardis, Mesri Alamdari, Naeimeh, Keshtkar, Abbasali, Akbari, Abolfazl, Vafa, Mohammadreza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Nutrition and Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640052/
https://www.ncbi.nlm.nih.gov/pubmed/28993384
http://dx.doi.org/10.1136/bmjopen-2017-016841

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640052/
https://www.ncbi.nlm.nih.gov/pubmed/28993384
http://dx.doi.org/10.1136/bmjopen-2017-016841

Ejemplares similares